β-blocker dialyzability in maintenance hemodialysis patients: A randomized clinical trial
Clinical Journal of the American Society of Nephrology Mar 29, 2018
Tieu A, et al. - Dialyzability of the most commonly prescribed β-blockers in patients undergoing high-flux hemodialysis was characterized. Relative to the negligible dialytic clearance of carvedilol, extensive clearance of atenolol and metoprolol by hemodialysis was reported. Bisoprolol was also found to be dialyzable.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries